Skip to main content
TipRanks
Go Ultimate75% OFF

Sprint Bioscience AB (SPRINT) Income Statement

1 Followers

Sprint Bioscience AB Income Statement

Last quarter (Q3 2026), Sprint Bioscience AB's total revenue was kr0.00, a decrease of 100.00% from the same quarter last year. In Q3, Sprint Bioscience AB's net income was kr-14.16M. See Sprint Bioscience AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 167.17Mkr 65.64Mkr 50.48Mkr 83.00Kkr 35.11M
kr 97.33Mkr 37.30Mkr 41.79Mkr -60.91Mkr 24.68M
kr 56.54Mkr 56.97Mkr 42.63Mkr 47.32Mkr 50.14M
Depreciation and Amortizationkr 1.07Mkr 958.00Kkr 447.00Kkr 618.00Kkr 590.00K
kr 98.40Mkr -17.32Mkr 396.00Kkr -60.00Mkr -24.49M
kr 97.33Mkr -19.67Mkr -845.00Kkr -60.91Mkr -25.47M
kr -5.59Mkr 1.39Mkr 407.00Kkr 739.00Kkr 383.00K
kr 91.74Mkr -18.28Mkr -438.00Kkr -60.17Mkr -25.08M
kr 91.74Mkr -18.28Mkr -438.00Kkr -60.17Mkr -25.35M
Per Share Metrics
Basic EPSkr 0.99kr -0.26kr -0.01kr -1.43kr -0.73
Diluted EPSkr 0.99kr -0.26kr -0.01kr -1.43kr -0.73
Weighted Average Shares Outstanding92.61M69.82M69.81M42.06M34.65M
Weighted Average Shares Outstanding (Diluted)92.61M69.82M69.81M42.06M34.65M

Currency in SEK

Sprint Bioscience AB Earnings and Revenue History

-100M0100M200M-80000 %-40000 %0 %40000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin